---
title: "BeOne Medicines and partners renew Brukinsa access programme for CLL"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296331290.md"
description: "BeOne Medicines and The Max Foundation have renewed their partnership to expand access to Brukinsa for chronic lymphocytic leukemia (CLL) patients. Building on a program that has already treated over 300 patients in Armenia, Ethiopia, and Nepal, the renewed agreement aims to reach approximately 1,000 patients cumulatively. Supported by donated drug and a $1m grant, the initiative will continue support in existing countries and potentially expand to others like Côte d’Ivoire and Malawi, ensuring ongoing treatment beyond 2028 if clinically required."
datetime: "2026-08-19T07:49:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296331290.md)
  - [en](https://longbridge.com/en/news/296331290.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296331290.md)
generator: "portal-rs"
---

# BeOne Medicines and partners renew Brukinsa access programme for CLL

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)

## Related News & Research

- [BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancer](https://longbridge.com/en/news/296930925.md)
- [Aaron Rosenberg Implements A Sell Strategy: Offloads $361K In BeOne Medicines Stock](https://longbridge.com/en/news/295122313.md)
- [IBM Just Opened Its Mainframes to Arm—Is the Market Missing the Shift?](https://longbridge.com/en/news/296932695.md)
- [MEDI: Record sales and profit in Q2/H1 2026, with strong growth in own products and key regions](https://longbridge.com/en/news/296576263.md)
- [ASM share buyback update August 17 – 21, 2026 | ASMIY Stock News](https://longbridge.com/en/news/296809617.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**